Skip to main content

Lavaca Capital LLC

SEC CIK
0001641447
Latest filing
Aug 14, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Lavaca Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
4,255
Value
$386.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Lavaca Capital LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,255$386.1K<0.1%+882+26.1%AddedHolders
Q1 20263,373$346.3K0.1%+1,078+47.0%AddedHolders
Q4 20252,295$287.5K<0.1%00.0%UnchangedHolders
Q3 20252,295$307.4K0.1%−1,469−39.0%ReducedHolders
Q2 20253,764$511.9K0.2%+6+0.2%AddedHolders
Q1 20253,758$498.5K0.2%+6+0.2%AddedHolders
Q4 20243,752$424.4K0.2%+6+0.2%AddedHolders
Q3 20243,746$427.1K0.2%+7+0.2%AddedHolders
Q2 20243,739$388.5K0.2%−2,793−42.8%ReducedHolders
Q1 20246,532$742.4K0.5%+301+4.8%AddedHolders
Q4 20236,231$685.8K0.4%−5,861−48.5%ReducedHolders
Q3 202312,092$1.17M0.4%−579−4.6%ReducedHolders
Q2 202312,671$1.38M0.4%−3,684−22.5%ReducedHolders
Q1 202316,355$1.71M0.4%+607+3.9%AddedHolders
Q4 202215,748$1.66M0.7%+2,825+21.9%AddedHolders
Q3 202212,923$1.32M0.7%−5,483−29.8%ReducedHolders
Q2 202218,406$2.03M1.0%+1,410+8.3%AddedHolders
Q1 202216,996$2.01M0.9%−11,993−41.4%ReducedHolders
Q4 202128,989$4.08M1.8%−193−0.7%ReducedHolders
Q3 202129,182$3.45M1.7%+2,114+7.8%AddedHolders
Q2 202127,068$3.14M1.6%+1,503+5.9%AddedHolders
Q1 202125,565$3.06M1.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.